1 Carey LA, "The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes" 13 : 2329-2334, 2007
2 Reyal F, "The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma" 6 : e20297-, 2011
3 Veronesi U, "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes" 349 : 1864-1867, 1997
4 Reynolds C, "Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?" 17 : 1720-1726, 1999
5 Gabos Z, "Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer" 24 : 5658-5663, 2006
6 Rahusen FD, "Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer" 136 : 1059-1063, 2001
7 Nos C, "Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases" 90 : 1354-1360, 2003
8 Schrenk P, "Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node" 92 : 707-713, 2005
9 Degnim AC, "Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram" 190 : 543-550, 2005
10 Reyal F, "Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification" 7 : e47390-, 2012
1 Carey LA, "The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes" 13 : 2329-2334, 2007
2 Reyal F, "The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma" 6 : e20297-, 2011
3 Veronesi U, "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes" 349 : 1864-1867, 1997
4 Reynolds C, "Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?" 17 : 1720-1726, 1999
5 Gabos Z, "Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer" 24 : 5658-5663, 2006
6 Rahusen FD, "Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer" 136 : 1059-1063, 2001
7 Nos C, "Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases" 90 : 1354-1360, 2003
8 Schrenk P, "Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node" 92 : 707-713, 2005
9 Degnim AC, "Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram" 190 : 543-550, 2005
10 Reyal F, "Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification" 7 : e47390-, 2012
11 Kohrt HE, "New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients" 8 : 66-, 2008
12 Zhou W, "Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes" 7 : e35881-, 2012
13 Perou CM, "Molecular portraits of human breast tumours" 406 : 747-752, 2000
14 Zhou WB, "Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast" 54 : 300-306, 2011
15 Cheang MC, "Ki67Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer" 101 : 736-750, 2009
16 Sørlie T, "Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications" 98 : 10869-10874, 2001
17 Chu KU, "Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?" 229 : 536-541, 1999
18 Moghaddam Y, "Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer" 97 : 1646-1652, 2010
19 Yin WJ, "Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients" 115 : 325-333, 2009
20 Hwang RF, "Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer" 10 : 248-254, 2003
21 Keshtgar MR, "Clinical role of sentinel-lymph-node biopsy in breast cancer" 3 : 105-110, 2002
22 Weigelt B, "Breast cancer molecular profiling with single sample predictors: a retrospective analysis" 11 : 339-349, 2010
23 Cheang MC, "Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype" 14 : 1368-1376, 2008
24 Cserni G, "Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer" 34 : 519-524, 2004
25 Wolff AC, "American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer" 25 : 118-145, 2007
26 Hammond ME, "American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer" 28 : 2784-2795, 2010
27 Lyman GH, "American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer" 23 : 7703-7720, 2005
28 Veronesi U, "A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer" 349 : 546-553, 2003
29 Van Zee KJ, "A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy" 10 : 1140-1151, 2003
30 Pal A, "A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive" 95 : 302-309, 2008